Juul   Report issue

For profit
Founded: San Francisco CA United States (2017)
Status: No NME R&D (2017)

Organization Overview

First Clinical Trial
2018
NCT03463837
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Juul Labs, Inc.

Active Ingredients

Drugs in Other Trials (2)

nicotine (nicorette) (2 trials)

tobacco (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 4
  • # of Trial APIs: 2